...
首页> 外文期刊>Nephrology. >B‐type natriuretic peptide is a useful biomarker for the estimation of volume overload in children with hypertension on peritoneal dialysis
【24h】

B‐type natriuretic peptide is a useful biomarker for the estimation of volume overload in children with hypertension on peritoneal dialysis

机译:B型利钠肽是一种有用的生物标志物,用于估计腹膜透析高血压儿童的体积过载

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

ABSTRACT Aim The aim of the present study was to evaluate the usefulness of serum B‐type natriuretic peptide (BNP) as a biomarker of fluid retention in hypertensive children on peritoneal dialysis (PD). Methods Hypertensive children on PD were included. The changes (?) of body weight (BWt), blood pressure (BP) and serum BNP at initial and follow‐up periods were reviewed. Data are presented as mean?±?standard deviation (median, minimum – maximum). Wilcoxon signed‐rank test was used to evaluate the changes in BWt, BP, and BNP. Linear regression analysis was applied for the correlation between the changes of BNP and BP. Results A total of 56 hypertensive events were evaluated in 30 patients. Initial findings were BWt 30.5?±?22.4 (26.5, 3.0–93.5) kg, systolic BP (SBP) 153.3?±?21.5 (150, 110–241) mmHg, diastolic BP (DBP) 100.1?±?22.3, (99.5, 49–181) mmHg, BNP 3579.3?±?6328.9 (1198.5, 305–22?028) pg/mL. Follow‐up results were BWt 29.1?±?21.3 (25.0, 3.12–86) kg, SBP 116.4?±?17.8 (117.5, 82–150) mmHg, DBP 73.3?±?14.2 (75.0, 42.0–101.0) mmHg, BNP 63.5?±?49.2 (60.5, 2–261) pg/mL. ?SBP (?23.1?±?13.8, ?22.8, ?46.9 ‐ 22.5%, P? 0.001), ?DBP (?24.1?±?19.2, ?24.7, ?55.6 – 23.2%, P? 0.001) and ?BNP (?93.5?±?8.1, ?96.7, ?99.9 – ‐61.0%, P? 0.001) dropped significantly after reduction of ?BWt (?4.8?±?4.7, ?4.8, ?18.7 – 5.6%, P? 0.001). The ?BNP were significantly correlated with ?SBP (adjusted R square?=?0.221, P? 0.001) and ?DBP (adjusted R square?=?0.203, P? 0.001). Conclusions Serum B‐type natriuretic peptide should be measured in hypertensive patients on PD to evaluate the volume status.
机译:摘要目的本研究的目的是评估血清B型利钠肽(BNP)作为腹膜透析(PD)上高血压儿童液体保留的生物标志物的有用性。方法包括PD上的高血压儿童。综述了体重(BWT),血压(BP),血压(BP)和血清BNP的变化(?)进行了综述。数据显示为平均值?±标准偏差(中位数,最小 - 最大值)。 Wilcoxon签名等级测试用于评估BWT,BP和BNP的变化。施加线性回归分析用于BNP和BP的变化之间的相关性。结果30名患者共评估了56例高血压事件。初始发现是BWT 30.5?±22.4(26.5,3.0-93.5)kg,收缩压BP(SBP)153.3?±21.5(150,110-241)mmHg,舒张压BP(DBP)100.1?±22.3,(99.5 ,49-181)MMHG,BNP 3579.3?±6328.9(1198.5,305-22?028)pg / ml。后续结果是BWT 29.1?±21.3(25.0,32-86)kg,SBP 116.4?±17.8(117.5,82-150)MMHG,DBP 73.3?±14.2(75.0,42.0-101.0)MMHG, BNP 63.5?±49.2(60.5,2-261)pg / ml。 ?SBP(?23.1?±13.8,α22.8,α46.9-22.5%,p?dbp(α20.1.001),?dbp(α20.1≤±±19.2,Δ24.7,?55.6-23.2%,p≤x≤0.001 )和?BNP(α93.5?±8.1,α96.7,α,α≤0.001)在减少后显着降低(?4.8?±4.7,?4.8,?18.7 - 5.6 %,p?<0.001)。 BNP与ΔBP显着相关(调节R平方θ=Δ= 0.221,p≤<0.001)和Δdbp(调节r square?= 0.203,p≤x≤0.001)。结论应在PD上的高血压患者中测量血清B型利钠肽,以评估体积状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号